Taiho Oncology and Servier Announce Positive Results from LONSURF® (trifluridine/tipiracil) Study Presented at ESMO 2018 Congress and Published in The Lancet Oncology
Lonsurf receives FDA priority review for metastatic gastric cancer, with a new study presented at ESMO 2018 Congress and published in The... Read More
A Risk-Scoring Model for Predicting Lymph Node Metastasis in Early Gastric Cancer Patients: a Retrospective Study and External Validation
Scientists test a risk-scoring mode for developing lymph node metastasis that can guide and personalize treatment for patients with early gastric cancer.
Immunohistochemical classification of gastric cancer based on new molecular biomarkers: a potential predictor of survival
New research shows immunohistochemical classification, the process of detecting antigens (e.x. proteins) in tissue cells, is associated with gender, outcomes, and other... Read More
Current Challenges in Gastric Cancer Surgery
Published in Elsevier Connect, researchers review recent trends in treating gastric cancer as well as new reconstructive methods improving post-op quality of... Read More
Long-term survival after liver metastasectomy in gastric cancer: Systematic review and meta-analysis of prognostic factors
With the liver a common site for gastric cancer recurrence, researchers in Elsevier Connect identified prognostic factors for using hepatectomy (liver removal)... Read More
Research Links Specific H. Pylori Strain with Stomach Cancer Risk
An interesting study published in PLOS Medicine identifies a specific H. pylori strain associated with gastric cancer risk.
CARsgen Therapeutics and CrownBio complete CAR-T study for gastric cancer
Research in its very early stages uses engineered immune cells (CAR-T) to target gastric cancer tumors.
Eating junk food tied to higher risk of numerous cancers
A new study in PLOS Medicine finds eating unhealthy food is associated with a higher risk of developing cancer, including stomach cancer.... Read More
Five Prime Therapeutics Completes Phase 1 Safety Lead-In and Initiates Phase 3, Global Registrational Trial of Bemarituzumab in Front-Line Advanced Gastric and Gastroesophageal Junction Cancers
A new phase 3 trial of Bemarituzumab for patients with advanced gastric cancer is open for enrollment. Curious about clinical trials? Use... Read More
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer
Research published in the American Society of Clinical Oncology shows nivolumab and nivolumab plus ipilimumab has durable response and encouraging long-term overall survivial... Read More
